Iterative Scopes, a 2017 spinout of MIT led by Jonathan Ng, announced today it closed a $30 million Series A financing led by new investors Obvious Ventures, with participation from Eli Lilly, Johnson & Johnson Innovation—JJDC Inc., venture capital firms Breyer Capital and Seae Ventures, and other leading healthcare investors. Proceeds from the investments will be used to continue developing the company’s AI-driven computational tools that help identify appropriate treatments and guide clinical trials for patients suffering from gastrointestinal diseases.
Search
Recent Posts
See AllBy: Catherine Shu Legacy healthcare software systems are often complicated and cumbersome for providers to use, leading to less time with patients. That’s why Regard (formerly HealthTensor) developed
By: Richard Gawel In 2020, guidelines changed to encourage parents and caregivers to introduce peanut and egg to infants aged 4 months to 6 months to help prevent food allergies. Yet many parents stil
Medicare Bundles See 55-70% Cost Savings with Luna's In-Home Outpatient PT Program, New Study Reveal
Luna announced the results of a retrospective analysis which demonstrated significant financial savings for those choosing in-home outpatient physical therapy (PT) compared to traditional home health
